Who invested in NiKang Therapeutics?
NiKang Therapeutics's investors include RA Capital Management, Wellington Management, BlackRock, Perceptive Advisors and Cormorant Asset Management.
Who invested in NiKang Therapeutics
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$200Mraised across 1 round since 2021, from 1 source
- Latest round
- Series C, $200MMay 2021
- Investors
- 5
The rounds
- May 2021Series C$200M
Source recordedSEC filing: $200M sold, first sale May 2021
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about NiKang Therapeutics
How much has NiKang Therapeutics raised?
NiKang Therapeutics has raised $200M across 1 round since 2021.
When did NiKang Therapeutics last raise?
NiKang Therapeutics's most recent round was a Series C of $200M in May 2021.
What was NiKang Therapeutics's biggest round?
Its most recent round, $200M in May 2021, is also its largest on record.
Who backed NiKang Therapeutics first?
NiKang Therapeutics's first round on record, in May 2021, was backed by RA Capital Management, Wellington Management and BlackRock and 2 others.
What stage is NiKang Therapeutics at?
NiKang Therapeutics's latest named round is a Series C, in May 2021.
Companies like NiKang Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.